Diagnostic delay still a barrier to effective PAH treatment: respiratory physician

The diagnostic delay which prevents early intervention in patients with PAH is not improving over time, according to data from the Pulmonary Hypertension Society of Australia and New Zealand registry between 2004 and 2017 The evidence from a cohort of more than 2,000 patients was that the mean diagnostic interval was 2.5 years. More than ...

Already a member?

Login to keep reading.

© 2021 the limbic